Are amblyopia treatments really all equal? Is that even the right question?
A series of Pediatric Eye Disease Investigator Group amblyopia treatment studies have concluded that the difference between patching and atropine penalization is inconsequential, and that there is no statistically significant difference between various amounts of prescribed patching. These results, representing mean behavior of groups of amblyopia patients, suggest that a broader range of initial treatments are appropriate than many previously believed; however, it is less clear how this informs treatment in individual cases.